Literature DB >> 29855656

Non-specific treatment effects and the patient perception of costly drug therapy.

N W Boone1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29855656     DOI： 10.1007/s00228-018-2491-8

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  3 in total

1.  Acceptable changes in quality attributes of glycosylated biopharmaceuticals.

Authors:  Martin Schiestl; Thomas Stangler; Claudia Torella; Tadej Cepeljnik; Hansjörg Toll; Roger Grau
Journal:  Nat Biotechnol       Date:  2011-04       Impact factor: 54.908

2.  Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists.

Authors:  Eline van Overbeeke; Birgit De Beleyr; Jan de Hoon; Rene Westhovens; Isabelle Huys
Journal:  BioDrugs       Date:  2017-10       Impact factor: 5.807

3.  The nocebo effect challenges the non-medical infliximab switch in practice.

Authors:  N W Boone; L Liu; M J Romberg-Camps; L Duijsens; C Houwen; P H M van der Kuy; R Janknegt; R Peeters; R B M Landewé; B Winkens; A A van Bodegraven
Journal:  Eur J Clin Pharmacol       Date:  2018-01-24       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.